Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Medication: Atypicals
Reinburg, S (2012). Antipsychotic drugs boost stroke risk. September 25, 2012.
http://abcnews.go.com/Health/Healthday/story?id=5681581&page=1#.UGXYlU-qXCc
Sheryl Sato
NURS 110
September 29, 2012
Introduction
An antipsychotic (or neuroleptic) is a
typical antipsychotics.
Second generation of
antipsychotics: atypical
antipsychotics.
Both generations of medication tend
Atypical
Antipsychotics
Mosapramine (Cremin)
Olanzapine (Zyprexa)
Paliperidone (Invega)
Clocapramine (Clofekton)
Perospirone (Lullan)
Clotiapine (Entumine)
Quetiapine (Seroquel)
Clozapine (Clozaril)
Remoxipride (Roxiam)
Iloperidone (Fanapt)
Risperidone (Risperdal)
Lurasidone (Latuda)
Pimavanserin (ACP-103)
Vabicaserin (SCA-136)
Sertindole (Serdolect)
Sulpiride (Sulprid, Eglonyl)
Ziprasidone (Geodon, Zeldox)
Zotepine (Nipolept)
Therapeutic Uses
Common Conditions:
Schizophrenia
Bipolar disorder
Delusional disorder
Therapeutic Uses
Antipsychotics have also been increasingly used off-
Dosages
Administration
Injectable form: (depot injection), usually
Pill form
Dosages
Adverse
Side
Effects
in women
lowered white blood cell count,
involuntary repetitive body movements
diabetes
sexual dysfunction
a return of psychosis requiring higher
medication dosages.
Advantage over
Typical Antipsychotics
In contrast, other researchers point to the significantly
higher risk of tardive dyskinesia and EPS with the
typicals and for this reason alone recommend first-line
treatment with the atypicals, notwithstanding a greater
propensity for metabolic adverse effects in the latter.
(Meltzer, 2006)
References
Reinberg, Steven. (2012). Antipsychotic drugs boost
References
Reinburg, S (2012). Antipsychotic drugs